184 related articles for article (PubMed ID: 23795874)
1. Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users.
Cunningham CO; Giovanniello A; Kunins HV; Roose RJ; Fox AD; Sohler NL
Am J Addict; 2013; 22(4):352-7. PubMed ID: 23795874
[TBL] [Abstract][Full Text] [Related]
2. Pain is not associated with worse office-based buprenorphine treatment outcomes.
Fox AD; Sohler NL; Starrels JL; Ning Y; Giovanniello A; Cunningham CO
Subst Abus; 2012; 33(4):361-5. PubMed ID: 22989279
[TBL] [Abstract][Full Text] [Related]
3. The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.
Sullivan LE; Botsko M; Cunningham CO; O'Connor PG; Hersh D; Mitty J; Lum PJ; Schottenfeld RS; Fiellin DA;
J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1(Suppl 1):S54-61. PubMed ID: 21317595
[TBL] [Abstract][Full Text] [Related]
4. Long-term retention in Office Based Opioid Treatment with buprenorphine.
Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
[TBL] [Abstract][Full Text] [Related]
5. Adherence to buprenorphine: An analysis of prescription drug monitoring program data.
Pizzicato LN; Hom JK; Sun M; Johnson CC; Viner KM
Drug Alcohol Depend; 2020 Nov; 216():108317. PubMed ID: 33035714
[TBL] [Abstract][Full Text] [Related]
6. Office-Based Buprenorphine Treatment: Identifying Factors That Promote Retention in Opioid-Dependent Patients.
Noe SR; Keller T
J Addict Nurs; 2020; 31(1):23-29. PubMed ID: 32132421
[TBL] [Abstract][Full Text] [Related]
7. Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes.
Cunningham CO; Roose RJ; Starrels JL; Giovanniello A; Sohler NL
J Addict Med; 2013; 7(4):287-93. PubMed ID: 23722632
[TBL] [Abstract][Full Text] [Related]
8. Engagement, retention, and abstinence for three types of opioid users in Florida.
McCabe BE; Santisteban DA; Mena MP; Duchene DM; McLean C; Monroe M
Subst Use Misuse; 2013 Jun; 48(8):623-34. PubMed ID: 23750774
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
Tofighi B; Grossman E; Goldfeld KS; Williams AR; Rotrosen J; Lee JD
Subst Use Misuse; 2015; 50(12):1571-8. PubMed ID: 26623697
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study.
Scott TM; Rivera Mindt M; Cunningham CO; Arias F; Coulehan K; Mangalonzo A; Olsen P; Arnsten JH
Subst Abuse Treat Prev Policy; 2017 Nov; 12(1):48. PubMed ID: 29141650
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.
Montoya ID; Gorelick DA; Preston KL; Schroeder JR; Umbricht A; Cheskin LJ; Lange WR; Contoreggi C; Johnson RE; Fudala PJ
Clin Pharmacol Ther; 2004 Jan; 75(1):34-48. PubMed ID: 14749690
[TBL] [Abstract][Full Text] [Related]
12. The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients.
Edelman EJ; Chantarat T; Caffrey S; Chaudhry A; O'Connor PG; Weiss L; Fiellin DA; Fiellin LE
Drug Alcohol Depend; 2014 Jun; 139():79-85. PubMed ID: 24726429
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting.
Sweeney MM; Prichett L; Fingerhood MI; Antoine D; Umbricht A; Dunn KE; Buresh ME
Am J Addict; 2022 May; 31(3):256-260. PubMed ID: 35385169
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
Curcio F; Franco T; Topa M; Baldassarre C;
Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
[TBL] [Abstract][Full Text] [Related]
15. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.
Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ
Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042
[TBL] [Abstract][Full Text] [Related]
16. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.
Holland R; Maskrey V; Swift L; Notley C; Robinson A; Nagar J; Gale T; Kouimtsidis C
Addiction; 2014 Apr; 109(4):596-607. PubMed ID: 24304349
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
[TBL] [Abstract][Full Text] [Related]
18. Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests.
Bagley SM; Cheng DM; Winter M; Alford DP; LaBelle C; Walley AY; Samet JH
Drug Alcohol Depend; 2018 Nov; 192():245-249. PubMed ID: 30290291
[TBL] [Abstract][Full Text] [Related]
19. Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use Disorder.
Chang HY; Daubresse M; Saloner B; Alexander GC
Med Care; 2019 Sep; 57(9):667-672. PubMed ID: 31404013
[TBL] [Abstract][Full Text] [Related]
20. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
